Effectiveness Trial of Locally Developed Ready to Use Therapeutic Food
Community-based Management of Acute Malnutrition (CMAM) in Bangladesh: Effectiveness Trial of Locally Developed Ready-to-use Therapeutic Food in the Treatment of Severe Acute Malnutrition in Rohingya Camps in Cox's Bazar
1 other identifier
interventional
450
1 country
2
Brief Summary
As poor health conditions and malnutrition are major issues confronting the influx of Forcibly Displaced Myanmar Nationals (FDMN), there is an urgent need to prepare the service providers to control the situation and to prevent deaths and disabilities in FDMN children suffering from severe acute malnutrition (SAM). It is therefore imperative to assess the effectiveness of the two local Nutrition Managements (NMs); Sharnali 1 \& Sharnali 2 for the treatment of SAM in an emergency in Bangladesh. If the effectiveness trial shows that the NMs are effective, either one or both varieties can be used for children with SAM in emergency situations. Ultimately a Bangladeshi solution will replace the expensive RUTF that is currently being imported for use in the FDMN camps for management of SAM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
August 30, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedDecember 21, 2022
December 1, 2022
2 years
May 19, 2022
December 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of children graduating from SAM to non-acute malnutrition status
The primary outcome variable is to assess the proportion of children graduating from SAM to non-acute malnutrition status (MUAC ≥ 125 mm or WLZ/WHZ ≥ -2 for two consecutive weeks) by 90 days of intervention
90 days
Secondary Outcomes (12)
Time (days) required to graduate from SAM to non-acute malnutrition status
90 days
Rate of weight gain of children (g/kg per day) during 1st 2 weeks, 1st 4 weeks and up to graduation
90 days
Proportion of children recovered (MUAC ≥ 125 mm or WLZ/WHZ ≥ -2) by different time periods
90 days
Changes in weight
90 days
Changes in Mid Upper Arm Circumference (MUAC)
90 days
- +7 more secondary outcomes
Study Arms (2)
To provide Sharnali-1 to severe acute malnourished children
EXPERIMENTALWe will provide Sharnali-1 among 225 severe acute malnourished children to assess the proportion of children graduating from SAM to non-acute malnutrition status (MUAC ≥ 125 mm or WLZ/WHZ ≥ -2 for two consecutive weeks) by 90 days of intervention.
To provide Sharnali-2 to severe acute malnourished children
EXPERIMENTALWe will provide Sharnali-2 among 225 severely acute malnourished children to assess the proportion of children graduating from SAM to non-acute malnutrition status (MUAC ≥ 125 mm or WLZ/WHZ ≥ -2 for two consecutive weeks) by 90 days of intervention.
Interventions
The intervention is food product, made from locally available food ingredients in Bangladesh. Sharnali 1 made from rice, lentil, dried skimmed milk, sugar, vegetable oils and micronutrient premix.
Sharnali 2 made from chick peas, dried skimmed milk, sugar, vegetable oils and micronutrient premix.
Eligibility Criteria
You may qualify if:
- Severe acute malnourished children
- Age 6-59 months
- Either sex
- No medical complication
- MUAC \<115 mm and/or WLZ/WHZ \<-3.
You may not qualify if:
- Children not suffering from severe acute malnutrition
- Children with oedematous malnutrition
- Failed to obtain consent for study participation from parents or legal guardian
- Suffering from any chronic illness(es) etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Teknāf, Cox's Bazar, Bangladesh
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Ukhiya, Cox's Bazar, Bangladesh
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Md Munirul Islam, PhD
Scientist
- PRINCIPAL INVESTIGATOR
Nurun Nahar Naila, MPH
Assistant Scientist
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The intervention study products will be packaged in sachets that cannot be differentiated between the two.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
August 30, 2022
Study Start
January 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
December 21, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share